CONMED Corporation Announces Quarterly Cash Dividend
December 05 2022 - 4:05PM
Business Wire
CONMED Corporation (NYSE: CNMD) today announced that its
Board of Directors has declared a quarterly cash dividend of $0.20
per share, payable on January 5, 2023, to all shareholders of
record as of December 16, 2022.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
thoracic surgery, and gastroenterology. For more information, visit
www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based
on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from
those in the forward-looking statements may include, but are not
limited to, the risks posed to the Company’s business, financial
condition, and results of operations by the COVID-19 global
pandemic and the various government and other responses to the
pandemic, including deferral of surgeries, reductions in hospital
and ambulatory surgery center operating volumes, disruption to
potential supply chain reliability, as well as the risk factors
discussed in the Company's Annual Report on Form 10-K for the full
year ended December 31, 2021, listed under the heading
Forward-Looking Statements in the Company’s most recently filed
Form 10-Q, and the risks associated with the timing and costs
related to the software implementation as further described in the
risk factors listed in the Current Report filed on Form 8-K on
November 15, 2022. Any and all forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995 and relate to the Company’s
performance on a going-forward basis. The Company believes that all
forward-looking statements made by it have a reasonable basis, but
there can be no assurance that management’s expectations, beliefs
or projections as expressed in the forward-looking statements will
actually occur or prove to be correct.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221205005702/en/
CONMED Corporation Todd Garner Chief Financial
Officer 727-214-2975 ToddGarner@conmed.com
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jul 2024 to Aug 2024
CONMED (NYSE:CNMD)
Historical Stock Chart
From Aug 2023 to Aug 2024